140 related articles for article (PubMed ID: 17163959)
1. Expression of prostate-specific antigen and androgen receptor in extramammary Paget's disease and carcinoma.
Inoguchi N; Matsumura Y; Kanazawa N; Morita K; Tachibana T; Sakurai T; Utani A; Miyachi Y
Clin Exp Dermatol; 2007 Jan; 32(1):91-4. PubMed ID: 17163959
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen-positive extramammary Paget's disease--association with prostate cancer.
Hammer A; Hager H; Steiniche T
APMIS; 2008 Jan; 116(1):81-8. PubMed ID: 18254784
[TBL] [Abstract][Full Text] [Related]
3. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor.
Diaz de Leon E; Carcangiu ML; Prieto VG; McCue PA; Burchette JL; To G; Norris BA; Kovatich AJ; Sanchez RL; Krigman HR; Gatalica Z
Am J Clin Pathol; 2000 Apr; 113(4):572-5. PubMed ID: 10761460
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease.
Battles OE; Page DL; Johnson JE
Am J Clin Pathol; 1997 Jul; 108(1):6-12. PubMed ID: 9208972
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor and 5alpha-reductase immunohistochemical profiles in extramammary Paget disease.
Kasashima S; Ozaki S; Kawashima A; Zen Y; Moriya T; Inoue M
Br J Dermatol; 2010 May; 162(5):1098-102. PubMed ID: 19995364
[TBL] [Abstract][Full Text] [Related]
6. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
[TBL] [Abstract][Full Text] [Related]
7. Evidence from mucin core protein expression that some Paget's disease on areola can be of extramammary-like histogenesis and part of multisite disease.
Ohnishi T; Shibuya S; Nemoto I; Koike S; Takizawa H; Suzuki T; Watanabe S
Br J Dermatol; 2004 Sep; 151(3):688-92. PubMed ID: 15377360
[TBL] [Abstract][Full Text] [Related]
8. Extramammary Paget's disease--a proliferation of adnexal origin?
Regauer S
Histopathology; 2006 May; 48(6):723-9. PubMed ID: 16681689
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
[TBL] [Abstract][Full Text] [Related]
10. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A
Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions.
Tanaka A; Kamiakito T; Takayashiki N; Sakurai S; Saito K
Virchows Arch; 2002 Oct; 441(4):380-4. PubMed ID: 12404063
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review.
Qiu YQ; Leuschner I; Braun PM
Asian J Androl; 2008 Nov; 10(6):855-63. PubMed ID: 18958349
[TBL] [Abstract][Full Text] [Related]
13. Triple extramammary Paget's disease.
Kitajima S; Yamamoto K; Tsuji T; Schwartz RA
Dermatol Surg; 1997 Nov; 23(11):1035-8. PubMed ID: 9391560
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 7 staining in mammary and extramammary Paget's disease.
Smith KJ; Tuur S; Corvette D; Lupton GP; Skelton HG
Mod Pathol; 1997 Nov; 10(11):1069-74. PubMed ID: 9388055
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors in skin appendage tumors and extramammary Paget's disease.
Lloveras B; Googe PB; Goldberg DE; Bhan AK
Mod Pathol; 1991 Jul; 4(4):487-90. PubMed ID: 1656434
[TBL] [Abstract][Full Text] [Related]
16. GnRH receptor and androgen receptor status and outcome of advanced prostate carcinomas.
Szabó J; Bartók K; Krenács T; Szepesváry Z; Szende B
Anticancer Res; 2009 Feb; 29(2):681-4. PubMed ID: 19331222
[TBL] [Abstract][Full Text] [Related]
17. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen in breast disease.
Poh BH; Jayaram G; Sthaneshwar P; Yip CH
Malays J Pathol; 2008 Jun; 30(1):43-51. PubMed ID: 19108411
[TBL] [Abstract][Full Text] [Related]
19. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M
Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder.
Chen JC; Ho CL; Tsai HW; Tzai TS; Liu HS; Chow NH; Yang WH; Cheng HL
Anticancer Res; 2008; 28(6B):4149-54. PubMed ID: 19192675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
